New York Peptide Laws & Regulations - PeptideLaws.com

New York has no statute, regulation, or Board of Pharmacy rule that names "peptides" or "research chemicals" as a distinct legal category, so their status in New York is determined by general federal drug law plus New York's ordinary prescription-drug and pharmacy-compounding rules. In practice, peptide drugs such as semaglutide-class compounds are prescription drugs that must be dispensed or compounded by a New York-licensed pharmacist under a valid prescription, and any pharmacy or outsourcing facility supplying them into New York must be registered with the NYS Education Department. Peptides sold as "research use only" chemicals are not carved out by New York law; they fall under the same federal misbranding/unapproved-drug framework the FDA enforces, and after the FDA resolved the semaglutide and tirzepatide shortages the federal basis for routine compounded GLP-1 production narrowed sharply. New York does have one adjacent consumer-protection restriction — a ban on selling over-the-counter weight-loss or muscle-building supplements to minors — but it targets marketing claims, not peptides as such.

• Searches of New York statutes, NYSED pharmacy regulations, and the New York State Senate/Assembly bill databases returned no New York law, rule, or pending bill that names peptides, BPC-157/TB-500-type compounds, or "research chemicals" as a distinct regulated category, so this conclusion reflects an absence of findings rather than an affirmative source. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
• New York Education Law § 6810 requires that drugs be compounded or dispensed by a licensed pharmacist and labeled with the prescriber and patient information, which is the general framework any prescription peptide product falls under in New York. [1]
• Under Education Law Article 137, out-of-state pharmacies, manufacturers, wholesalers, and outsourcing facilities that ship or deliver prescription drugs into New York must be registered with the Education Department, meaning mail-order peptide suppliers shipping prescription drugs into the state need New York registration. [2]
• New York maintains a separate registration pathway and application requirements for outsourcing facilities (the federal 503B category), administered by the Office of the Professions' pharmacy establishment unit. [3]
• New York's Commissioner of Education regulations (Part 63) set physical, storage, and sterile-compounding conditions for registered pharmacies, and applications for establishments doing sterile compounding are handled on a longer review timeline than non-sterile ones — these general compounding rules, not any peptide-specific rule, govern compounded injectable peptides in New York. [4]
• New York schedules anabolic steroids at the state level in subdivision (h) of Schedule II of Public Health Law § 3306, with DOH regulations carving out limited exemptions — relevant because hormone-adjacent products can be state-scheduled even though research peptides such as BPC-157 and TB-500 are not listed. [5]
• New York General Business Law § 391-oo, effective April 22, 2024, bars retail sale to anyone under 18 of over-the-counter dietary supplements labeled or marketed for weight loss or muscle building, and the Second Circuit declined to strike the law down in November 2025 — the closest New York-specific rule touching peptide-adjacent products. [6]
• Because the FDA determined the semaglutide and tirzepatide shortages resolved and the enforcement-discretion periods ended in 2025, the federal basis for routine compounded GLP-1 production narrowed, and FDA has issued warning letters treating marketing claims for compounded semaglutide and tirzepatide as false or misleading under the FDCA — federal actions that control in New York in the absence of a state rule. [7]

Last researched: 2026-08-10

Note: This page provides general information based on the sourced research above. For specific legal questions in New York, consult with a licensed attorney familiar with pharmaceutical law.